Jpmorgan Chase & Co »

Aziyo Biologics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Aziyo Biologics (ELUT) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Aziyo Biologics

Tip: Access up to 7 years of quarterly data

All positions including Aziyo Biologics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aziyo Biologics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $76 24 3.17
2023-12-31 $27 13 2.15
2023-09-30 $5.3k 3.7k 1.43
2021-03-31 $85k 6.3k 13.42
2020-12-31 $84k 6.1k 13.70